|
1
|
Moga MA, Dima L, Balan A, Blidaru A,
Dimienescu OG, Podasca C and Toma S: Are bioactive molecules from
seaweeds a novel and challenging option for the prevention of HPV
infection and cervical cancer therapy?-A review. Int J Mol Sci.
22:6292021. View Article : Google Scholar
|
|
2
|
Davies-Oliveira JC, Smith MA, Grover S,
Canfell K and Crosbie EJ: Eliminating cervical cancer: Progress and
challenges for high-income countries. Clin Oncol (R Coll Radiol).
33:550–559. 2021. View Article : Google Scholar
|
|
3
|
Buskwofie A, David-West G and Clare CA: A
review of cervical cancer: Incidence and disparities. J Natl Med
Assoc. 112:229–232. 2020.PubMed/NCBI
|
|
4
|
Li H, Wu X and Cheng X: Advances in
diagnosis and treatment of metastatic cervical cancer. J Gynecol
Oncol. 27:e432016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hill EK: Updates in cervical cancer
treatment. Clin Obstet Gynecol. 63:3–11. 2020. View Article : Google Scholar
|
|
6
|
Liontos M, Kyriazoglou A, Dimitriadis I,
Dimopoulos MA and Bamias A: Systemic therapy in cervical cancer: 30
Years in review. Crit Rev Oncol Hematol. 137:9–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao Z, Yang P and Zhou Q: Multiple
biological functions and pharmacological effects of lycorine. Sci
China Chem. 56:1382–1391. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiang Y, Guo Z, Zhu P, Chen J and Huang Y:
Traditional Chinese medicine as a cancer treatment: Modern
perspectives of ancient but advanced science. Cancer Med.
8:1958–1975. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhai B, Zhang N, Han X, Li Q, Zhang M,
Chen X, Li G, Zhang R, Chen P, Wang W, et al: Molecular targets of
β-elemene, a herbal extract used in traditional Chinese medicine,
and its potential role in cancer therapy: A review. Biomed
Pharmacother. 114:1088122019. View Article : Google Scholar
|
|
10
|
Zhang P, Yuan X, Yu T, Huang H, Yang C,
Zhang L, Yang S, Luo X and Luo J: Lycorine inhibits cell
proliferation, migration and invasion, and primarily exerts in
vitro cytostatic effects in human colorectal cancer via activating
the ROS/p38 and PI3K/AKT signaling pathways. Oncol Rep. 45:192021.
View Article : Google Scholar
|
|
11
|
Shang H, Jang X, Shi L and Ma Y: Lycorine
inhibits cell proliferation and induced oxidative stress-mediated
apoptosis via regulation of the JAK/STAT3 signaling pathway in HT-3
cells. J Biochem Mol Toxicol. 35:e228822021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi J, Zhao H, Lian H, Ke L, Zhao L, Wang
C and Han Q: CD276 (B7H3) improve cancer stem cells formation in
cervical carcinoma cell lines. Transl Cancer Res. 10:65–72. 2021.
View Article : Google Scholar
|
|
13
|
Xu Y, Wu H, Huang C and Lu L: Clinical
value of traditional laparotomy, extensive vaginal hysterectomy,
and laparoscope-assisted vaginal hysterectomy in the treatment of
patients with cervical intraepithelial neoplasia III. Transl Cancer
Res. 10:2409–2415. 2021. View Article : Google Scholar
|
|
14
|
Wang W, Gao X, Zhu Y, Qi Y and Wang Y:
Diagnostic significance of a color Doppler ultrasound combined with
serum CXCL16 and E-cad in cervical cancer. Transl Cancer Res.
10:1492–1499. 2021. View Article : Google Scholar
|
|
15
|
Li Z, Wang S, Fang S, Li X, Li Y and Liu
G: Adipose-derived stem cells promote the proliferation, migration,
and invasion of oral squamous cell carcinoma cells by activating
the Wnt/planar cell polarity signaling pathway. Transl Cancer Res.
11:306–315. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the care and use of laboratory animals. 8th
edition: Washington (DC): National Academies Press (US); 2011
|
|
18
|
Li Z, Fan X, Xu X, Zhou Q, Xing G and Liu
G: Adipose-derived stem cells postpone the progression of Sjögren's
syndrome by upregulating the Hippo signaling pathway. Exp Ther Med.
24:5872022. View Article : Google Scholar
|
|
19
|
Hu M, Tan J, Liu Z, Li L, Zhang H, Zhao D,
Li B, Gao X, Che N and Zhang T: Comprehensive comparative molecular
characterization of young and old lung cancer patients. Front
Oncol. 11:8068452022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jung JH, Lee H, Zeng SX and Lu H: RBM10, a
new regulator of p53. Cells. 9:21072020. View Article : Google Scholar :
|
|
21
|
Witkiewicz AK, McMillan EA, Balaji U, Baek
G, Lin WC, Mansour J, Mollaee M, Wagner KU, Koduru P, Yopp A, et
al: Whole-exome sequencing of pancreatic cancer defines genetic
diversity and therapeutic targets. Nat Commun. 6:67442015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang K, Bacon ML, Tessier JJ, Rintala-Maki
ND, Tang V and Sutherland LC: RBM10 modulates apoptosis and
influences TNF-α gene expression. J Cell Death. 5:1–19. 2012.
View Article : Google Scholar
|
|
23
|
Jung JH, Lee H, Cao B, Liao P, Zeng SX and
Lu H: RNA-binding motif protein 10 induces apoptosis and suppresses
proliferation by activating p53. Oncogene. 39:1031–1040. 2020.
View Article : Google Scholar :
|
|
24
|
Han LP, Wang CP and Han SL: Overexpression
of RBM10 induces osteosarcoma cell apoptosis and inhibits cell
proliferation and migration. Med Sci (Paris). 34:81–86. 2018.
View Article : Google Scholar
|
|
25
|
Stratos I, Behrendt AK, Anselm C, Gonzalez
A, Mittlmeier T and Vollmar B: Inhibition of TNF-α restores muscle
force, inhibits inflammation, and reduces apoptosis of traumatized
skeletal muscles. Cells. 11:23972022. View Article : Google Scholar
|
|
26
|
Ji Y, Xie S, Jiang L, Liu L, Li L, Luo L,
Chen Y, Zhang J, Yu L, Zhang Y, et al: Increased cell apoptosis in
human lung adenocarcinoma and in vivo tumor growth inhibition by
RBM10, a tumor suppressor gene. Oncol Lett. 14:4663–4669. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao Y, Di X, Zhang Q, Li R and Wang K:
RBM10 regulates tumor apoptosis, proliferation, and metastasis.
Front Oncol. 11:6039322021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao J, Zhang P and Wang X: YBX1 promotes
tumor progression via the PI3K/AKT signaling pathway in laryngeal
squamous cell carcinoma. Transl Cancer Res. 10:4859–4869. 2021.
View Article : Google Scholar
|
|
29
|
Tateishi K, Nakamura T, Juratli TA,
Williams EA, Matsushita Y, Miyake S, Nishi M, Miller JJ, Tummala
SS, Fink AL, et al: PI3K/AKT/mTOR pathway alterations promote
malignant progression and xenograft formation in oligodendroglial
tumors. Clin Cancer Res. 25:4375–4387. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng M, Zhou Q, Liu X, Wang C and Liu G:
CTHRC1 overexpression promotes cervical carcinoma progression by
activating the Wnt/PCP signaling pathway. Oncol Rep. 41:1531–1538.
2019.PubMed/NCBI
|
|
31
|
Castillo Ferrer C, Berthenet K and Ichim
G: Apoptosis-fueling the oncogenic fire. FEBS J. 288:4445–4463.
2021. View Article : Google Scholar
|
|
32
|
Obeng E: Apoptosis (programmed cell death)
and its signals-a review. Braz J Biol. 81:1133–1143. 2021.
View Article : Google Scholar
|
|
33
|
Inoue A: RBM10: Structure, functions, and
associated diseases. Gene. 783:1454632021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He Y, Wang W, Xu X, Yang B, Yu X, Wu Y and
Wang J: Mettl3 inhibits the apoptosis and autophagy of chondrocytes
in inflammation through mediating Bcl2 stability via
Ythdf1-mediated m6A modification. Bone. 154:1161822022.
View Article : Google Scholar
|
|
35
|
Song M, Bode AM, Dong Z and Lee MH: AKT as
a therapeutic target for cancer. Cancer Res. 79:1019–1031. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Revathidevi S and Munirajan AK: Akt in
cancer: Mediator and more. Semin Cancer Biol. 59:80–91. 2019.
View Article : Google Scholar : PubMed/NCBI
|
